Daewoong Pharmaceutical, TionLab Therapeutics join hands to develop monthly obesity injectable

--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-05-08 14:12 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Economy & Finance, Financial Markets, World News, Business & Economy
--------------------------------------------------------------------
Snippet:
Daewoong Pharmaceutical said Friday it signed a strategic partnership agreement with TionLab Therapeutics to jointly develop and commercialize long-acting monthly semaglutide injectable to the global market.
--------------------------------------------------------------------
>>> Read full article at The Korea Herald <<<
<-- Back to Home
< >
[Close]